Improving clinical outcomes via responsible antimicrobial use in horses
Author:
Open Access
- 3 June 2021
- journal article
- review article
- Published by Wiley in Equine Veterinary Education
- Vol. 34 (9) , 482-492
Abstract
Summary: The growing problem of antimicrobial resistance affects veterinarians on a daily basis. Antimicrobial stewardship and responsible prescribing are essential for a future with effective antimicrobials, as it is unlikely that new antimicrobials will become available for use in horses in the near future. Extended‐spectrum β‐lactamase (ESBL) producing Enterobacteriaceae , methicillin‐resistant Staphylococcus aureus (MRSA) and Salmonella spp. are pathogens of significant concern but there are also other opportunistic pathogens such as Pseudomonas spp., α‐haemolytic Streptococcu s spp., Enterococcus spp. and Acinetobacter spp. which, due to their high intrinsic resistance, have limited treatment options in adult horses. It is essential that highest priority critically important antimicrobials such as ceftiofur, enrofloxacin, rifampicin and polymyxin B are used prudently in horses and ideally based on culture and antimicrobial susceptibility testing (AST). For example, the use of polymyxin B at a low anti‐endotoxic dose rather than at a higher antimicrobial dose in horses for the treatment of systemic inflammatory response syndrome is a potential driver for resistance to colistin (polymyxin E), an antimicrobial used as a last resort in the treatment of multidrug resistant (MDR) Enterobacteriaceae infections in humans. Serum procalcitonin levels are used in humans to distinguish noninfectious inflammatory conditions from inflammation caused by bacteria and other infectious agents and are also used to guide cessation of antimicrobial treatment. Although no such studies have been performed in horses, this or other markers may prove to be helpful in guiding antimicrobial treatment decisions in the future. Optimising sampling techniques and good communication with the microbiology laboratory are essential for generating the accurate culture and AST results that underpin appropriate antimicrobial use. Additionally, there is clearly a need for national and international harmonisation of laboratory methods in order to improve the reliability and consistency of results reported by different laboratories.Keywords
Funding Information
- The Horse Trust (G2015)
This publication has 99 references indexed in Scilit:
- ColistinJournal of Postgraduate Medicine, 2013
- Evaluation of the Efficacy and Safety of High Dose Short Duration Enrofloxacin Treatment Regimen for Uncomplicated Urinary Tract Infections in DogsJournal of Veterinary Internal Medicine, 2012
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistanceClinical Microbiology and Infection, 2012
- Procalcitonin Algorithms for Antibiotic Therapy DecisionsArchives of internal medicine (1960), 2011
- Selection of Resistant Bacteria at Very Low Antibiotic ConcentrationsPLOS Pathogens, 2011
- Selective Advantage of Resistant Strains at Trace Levels of Antibiotics: a Simple and Ultrasensitive Color Test for Detection of Antibiotics and Genotoxic AgentsAntimicrobial Agents and Chemotherapy, 2011
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Effectiveness and safety of short vs. long duration of antibiotic therapy for acute bacterial sinusitis: a meta‐analysis of randomized trialsBritish Journal of Clinical Pharmacology, 2009
- Clusters of Infections in Horses with MRSA ST1, ST254, and ST398 in a Veterinary HospitalMicrobial Drug Resistance, 2008
- Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*Critical Care Medicine, 2006